HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS

Heterocyclic compounds as CDK4 or CDK6 or other CDK inhibitors are provided. The compounds may find use as therapeutic agents for the treatment of diseases and may find particular use in oncology. L'invention concerne des composés hétérocycliques utilisés en tant qu'inhibiteurs de CDK4 ou...

Full description

Saved in:
Bibliographic Details
Main Authors CHEN, Jiyun, PHAM, Son Minh, GANGAR, Mukesh, KANKANALA, Jayakanth, BHATT, Bhawana, SHETE, Amit S, CHAKRAVARTY, Sarvajit, PUJALA, Brahmam
Format Patent
LanguageEnglish
French
Published 18.02.2021
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:Heterocyclic compounds as CDK4 or CDK6 or other CDK inhibitors are provided. The compounds may find use as therapeutic agents for the treatment of diseases and may find particular use in oncology. L'invention concerne des composés hétérocycliques utilisés en tant qu'inhibiteurs de CDK4 ou de CDK6 ou d'autres inhibiteurs de CDK. Les composés peuvent trouver une utilité en tant qu'agents thérapeutiques pour le traitement de maladies et peuvent être particulièrement utiles en oncologie.
Bibliography:Application Number: WO2020US46230